Rossari Biotech Share Price
446.50-8.30 (-1.82%)
-31.77% past 1 Year
Prices are delayed by 1 hour. Login or Sign Up for live updates.Prices are delayed by 1 hour. Login or Sign Up for live updates.
Price Analysis
About
Stock Analysis (SWOT)
QVT
Peer Stocks
1 week
1 month
1 year
Name
SOLARINDSNSE
PIDILITINDNSE
SRFNSE
FLUOROCHEMNSE
GODREJINDNSE
DEEPAKNTRNSE
AETHERNSE
ATULNSE
AARTIINDNSE
ROSSARINSE
Rossari Biotech Share Price
446.50-8.30 (-1.82%)
-31.77% past 1 Year
Financial overview
Compounded Sales Growth
Compounded Profit Growth
Stock Price CAGR
Return on Equity
CAGR%
Sales
Profits
Returns
ROE
| 10Y | 5Y | 3Y | TTM |
|---|---|---|---|
| 30% | 28% | 13% | 15% |
| 46% | 13% | 12% | 9% |
| - | -21% | -18% | -31% |
| 23% | 13% | 12% | 12% |
Peer Comparison
Symbol
SOLARINDS
PIDILITIND
SRF
FLUOROCHEM
NAVINFLUOR
GODREJIND
DEEPAKNTR
AETHER
ATUL
AARTIIND
ROSSARI
| Price | M.Cap (₹) | PE Ratio | EPS (₹) | EV/EBITDA | Annual PAT |
|---|---|---|---|---|---|
| 19,480 | ₹178446 Cr | 89.61 | 72.11 | 250.42 | ₹1678 Cr |
| 1,522 | ₹161540 Cr | 60.98 | 8.57 | 29.89 | ₹2449 Cr |
| 2,533.8 | ₹75295 Cr | 34.83 | 25.6 | 102.33 | ₹1835 Cr |
| 4,471 | ₹49109 Cr | 79.85 | 20.09 | 90.49 | ₹577 Cr |
| 8,446 | ₹43357 Cr | 54.9 | 47.43 | 184.25 | ₹664 Cr |
| 1,091 | ₹37273 Cr | 31.7 | 8.44 | 50.37 | ₹1241 Cr |
| 1,600.9 | ₹22311 Cr | 28.48 | 25.29 | 74.81 | ₹551 Cr |
| 1,648 | ₹21914 Cr | 93.18 | 4.73 | 23.27 | ₹219 Cr |
| 6,135.5 | ₹18016 Cr | 22.65 | 83.32 | 378.24 | ₹678 Cr |
| 490.8 | ₹17812 Cr | 33.54 | 4.28 | 27.98 | ₹419 Cr |
| 445 | ₹2516 Cr | 16.69 | 6.34 | 42.91 | ₹149 Cr |
Profit & Loss
Consolidated
Standalone
Quarterly
Yearly
₹
%
Balance Sheet
Consolidated
Standalone
₹
%
Name
Equity And Liabilities
Share Capital
Share Warrants & Outstandings
Total Reserves
Reserve excluding Revaluation Reserve
Shareholder's Funds
Secured Loans
Deferred Tax Assets / Liabilities
Other Long Term Liabilities
Long Term Provisions
Total Non-Current Liabilities
Current Liabilities
Trade Payables
Other Current Liabilities
Short Term Borrowings
Short Term Provisions
Total Current Liabilities
Total Liabilities
Contingent Liabilities
Total Debt
Assets
Gross Block
Less Accumulated Depreciation
Net Block
Capital Work in Progress
Non Current Investments
Long Term Investment
Long Term Loans & Advances
Other Non Current Assets
Total Non-Current Assets
Current Assets Loans & Advances
Currents Investments
Inventories
Sundry Debtors
Cash and Bank
Other Current Assets
Short Term Loans and Advances
Total Current Assets
Net Current Assets (Including Current Investments)
Total Assets
Book Value
Adjusted Book Value
| Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 | Mar 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| — | — | — | — | — | — | — | — | — | — | — | — | — |
| ₹11 Cr | ₹11 Cr | ₹11 Cr | ₹11 Cr | ₹11 Cr | ₹10 Cr | ₹10 Cr | ₹4 Cr | ₹4 Cr | ₹4 Cr | ₹4 Cr | ₹4 Cr | ₹4 Cr |
| ₹5 Cr | ₹2 Cr | ₹4 Cr | ₹4 Cr | ₹3 Cr | ₹2 Cr | ₹49 L | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹4 Cr |
| ₹1317 Cr | ₹1172 Cr | ₹1033 Cr | ₹901 Cr | ₹791 Cr | ₹396 Cr | ₹276 Cr | ₹119 Cr | ₹90 Cr | ₹61 Cr | ₹46 Cr | ₹42 Cr | ₹40 Cr |
| ₹1317 Cr | ₹1172 Cr | ₹1033 Cr | ₹901 Cr | ₹791 Cr | ₹396 Cr | ₹276 Cr | ₹119 Cr | ₹90 Cr | ₹61 Cr | ₹46 Cr | ₹42 Cr | ₹40 Cr |
| ₹1333 Cr | ₹1185 Cr | ₹1048 Cr | ₹915 Cr | ₹805 Cr | ₹409 Cr | ₹287 Cr | ₹124 Cr | ₹94 Cr | ₹65 Cr | ₹50 Cr | ₹47 Cr | ₹48 Cr |
| ₹94 Cr | ₹100 Cr | ₹33 Cr | ₹35 Cr | ₹0 | ₹0 | ₹34 Cr | ₹67 L | ₹1 Cr | ₹2 Cr | ₹7 Cr | ₹9 Cr | ₹7 Cr |
| ₹28 Cr | ₹36 Cr | ₹47 Cr | ₹56 Cr | ₹68 Cr | ₹98 L | ₹49 L | ₹2 Cr | -₹71 L | -₹40 L | -₹25 L | ₹4 L | ₹44 L |
| ₹20 Cr | ₹22 Cr | ₹11 Cr | ₹8 Cr | ₹85 Cr | ₹0 | ₹0 | ₹0 | ₹3 Cr | ₹0 | ₹0 | ₹0 | ₹0 |
| ₹172 Cr | ₹103 Cr | ₹102 Cr | ₹82 Cr | ₹99 Cr | ₹58 Cr | ₹35 Cr | ₹35 Cr | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| ₹315 Cr | ₹262 Cr | ₹193 Cr | ₹181 Cr | ₹251 Cr | ₹59 Cr | ₹69 Cr | ₹37 Cr | ₹4 Cr | ₹2 Cr | ₹7 Cr | ₹9 Cr | ₹8 Cr |
| — | — | — | — | — | — | — | — | — | — | — | — | — |
| ₹323 Cr | ₹286 Cr | ₹219 Cr | ₹181 Cr | ₹186 Cr | ₹131 Cr | ₹97 Cr | ₹106 Cr | ₹40 Cr | ₹32 Cr | ₹28 Cr | ₹18 Cr | ₹28 Cr |
| ₹165 Cr | ₹155 Cr | ₹128 Cr | ₹126 Cr | ₹100 Cr | ₹17 Cr | ₹20 Cr | ₹12 Cr | ₹6 Cr | ₹4 Cr | ₹7 Cr | ₹8 Cr | ₹11 Cr |
| ₹284 Cr | ₹75 Cr | ₹63 Cr | ₹29 Cr | ₹0 | ₹0 | ₹27 Cr | ₹3 Cr | ₹19 Cr | ₹20 Cr | ₹15 Cr | ₹30 Cr | ₹29 Cr |
| ₹234 Cr | ₹223 Cr | ₹174 Cr | ₹140 Cr | ₹74 Cr | ₹28 Cr | ₹24 Cr | ₹63 L | ₹3 Cr | ₹1 Cr | ₹2 Cr | ₹2 Cr | ₹1 Cr |
| ₹1007 Cr | ₹740 Cr | ₹584 Cr | ₹476 Cr | ₹360 Cr | ₹177 Cr | ₹169 Cr | ₹122 Cr | ₹68 Cr | ₹57 Cr | ₹52 Cr | ₹58 Cr | ₹70 Cr |
| ₹2655 Cr | ₹2187 Cr | ₹1825 Cr | ₹1572 Cr | ₹1417 Cr | ₹645 Cr | ₹525 Cr | ₹283 Cr | ₹166 Cr | ₹124 Cr | ₹109 Cr | ₹114 Cr | ₹125 Cr |
| ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹11 L | ₹22 L | ₹31 L | ₹29 L |
| ₹408 Cr | ₹188 Cr | ₹106 Cr | ₹74 Cr | ₹8 Cr | ₹0 | ₹67 Cr | ₹5 Cr | ₹21 Cr | ₹22 Cr | ₹22 Cr | ₹44 Cr | ₹44 Cr |
| — | — | — | — | — | — | — | — | — | — | — | — | — |
| ₹1133 Cr | ₹878 Cr | ₹791 Cr | ₹743 Cr | ₹704 Cr | ₹234 Cr | ₹122 Cr | ₹86 Cr | ₹88 Cr | ₹76 Cr | ₹38 Cr | ₹67 Cr | ₹67 Cr |
| ₹349 Cr | ₹279 Cr | ₹213 Cr | ₹158 Cr | ₹97 Cr | ₹53 Cr | ₹29 Cr | ₹12 Cr | ₹43 Cr | ₹38 Cr | ₹0 | ₹30 Cr | ₹25 Cr |
| ₹784 Cr | ₹598 Cr | ₹578 Cr | ₹585 Cr | ₹607 Cr | ₹181 Cr | ₹94 Cr | ₹74 Cr | ₹45 Cr | ₹38 Cr | ₹38 Cr | ₹38 Cr | ₹42 Cr |
| ₹173 Cr | ₹140 Cr | ₹47 Cr | ₹13 Cr | ₹1 Cr | ₹32 L | ₹22 Cr | ₹3 Cr | ₹10 Cr | ₹8 Cr | ₹8 Cr | ₹7 Cr | ₹7 Cr |
| ₹27 Cr | ₹26 Cr | ₹25 Cr | ₹25 Cr | ₹24 Cr | ₹0 | ₹4 Cr | ₹0 | ₹3 Cr | ₹25,400 | ₹25,400 | ₹25,400 | ₹25,400 |
| ₹27 Cr | ₹26 Cr | ₹25 Cr | ₹25 Cr | ₹24 Cr | ₹0 | ₹4 Cr | ₹0 | ₹3 Cr | ₹25,400 | ₹25,400 | ₹25,400 | ₹25,400 |
| ₹206 Cr | ₹175 Cr | ₹171 Cr | ₹96 Cr | ₹109 Cr | ₹62 Cr | ₹58 Cr | ₹39 Cr | ₹2 Cr | ₹80 L | ₹65 L | ₹59 L | ₹53 L |
| ₹3 Cr | ₹11 L | ₹7 L | ₹12 L | ₹36 L | ₹20 Cr | ₹42 L | ₹7 Cr | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| ₹1194 Cr | ₹940 Cr | ₹821 Cr | ₹723 Cr | ₹742 Cr | ₹263 Cr | ₹178 Cr | ₹123 Cr | ₹60 Cr | ₹47 Cr | ₹46 Cr | ₹46 Cr | ₹50 Cr |
| — | — | — | — | — | — | — | — | — | — | — | — | — |
| ₹35 Cr | ₹57 Cr | ₹38 Cr | ₹26 Cr | ₹12 Cr | ₹0 | ₹14 Cr | ₹0 | ₹4 Cr | ₹0 | ₹0 | ₹0 | ₹0 |
| ₹405 Cr | ₹355 Cr | ₹282 Cr | ₹188 Cr | ₹190 Cr | ₹95 Cr | ₹58 Cr | ₹55 Cr | ₹35 Cr | ₹24 Cr | ₹25 Cr | ₹31 Cr | ₹42 Cr |
| ₹557 Cr | ₹475 Cr | ₹425 Cr | ₹354 Cr | ₹305 Cr | ₹144 Cr | ₹94 Cr | ₹86 Cr | ₹60 Cr | ₹47 Cr | ₹31 Cr | ₹30 Cr | ₹28 Cr |
| ₹92 Cr | ₹57 Cr | ₹30 Cr | ₹124 Cr | ₹52 Cr | ₹88 Cr | ₹127 Cr | ₹6 Cr | ₹76 L | ₹2 Cr | ₹3 Cr | ₹1 Cr | ₹99 L |
| ₹5 Cr | ₹3 Cr | ₹2 Cr | ₹3 Cr | ₹6 Cr | ₹2 Cr | ₹5 Cr | ₹89 L | ₹32 L | ₹10 L | ₹12 L | ₹14 L | ₹17 L |
| ₹359 Cr | ₹299 Cr | ₹225 Cr | ₹152 Cr | ₹111 Cr | ₹52 Cr | ₹48 Cr | ₹12 Cr | ₹5 Cr | ₹4 Cr | ₹4 Cr | ₹6 Cr | ₹5 Cr |
| ₹1453 Cr | ₹1246 Cr | ₹1003 Cr | ₹847 Cr | ₹675 Cr | ₹381 Cr | ₹346 Cr | ₹160 Cr | ₹106 Cr | ₹77 Cr | ₹63 Cr | ₹69 Cr | ₹76 Cr |
| ₹446 Cr | ₹505 Cr | ₹419 Cr | ₹372 Cr | ₹315 Cr | ₹205 Cr | ₹178 Cr | ₹38 Cr | ₹38 Cr | ₹20 Cr | ₹11 Cr | ₹10 Cr | ₹6 Cr |
| ₹2655 Cr | ₹2187 Cr | ₹1825 Cr | ₹1572 Cr | ₹1417 Cr | ₹645 Cr | ₹525 Cr | ₹283 Cr | ₹166 Cr | ₹124 Cr | ₹109 Cr | ₹114 Cr | ₹125 Cr |
| ₹240 | ₹214 | ₹189 | ₹165 | ₹146 | ₹78 | ₹56 | ₹281 | ₹214 | ₹149 | ₹114 | ₹107 | ₹101 |
| ₹240 | ₹214 | ₹189 | ₹165 | ₹146 | ₹78 | ₹56 | ₹26 | ₹19 | ₹14 | ₹10 | ₹10 | ₹9 |
Cash Flow
Consolidated
Standalone
₹
%
Name
Profit Before Tax
Adjustment
Changes In working Capital
Cash Flow after changes in Working Capital
Cash Flow from Operating Activities
Cash Flow from Investing Activities
Cash Flow from Financing Activitie
Net Cash Inflow / Outflow
Opening Cash & Cash Equivalents
Effect of Foreign Exchange Fluctuations
Closing Cash & Cash Equivalent
| Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 | Mar 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ₹203 Cr | ₹185 Cr | ₹178 Cr | ₹144 Cr | ₹136 Cr | ₹107 Cr | ₹88 Cr | ₹63 Cr | ₹40 Cr | ₹19 Cr | ₹5 Cr | ₹5 Cr | ₹4 Cr |
| ₹85 Cr | ₹84 Cr | ₹76 Cr | ₹83 Cr | ₹55 Cr | ₹21 Cr | ₹20 Cr | ₹17 Cr | ₹6 Cr | ₹6 Cr | ₹7 Cr | ₹9 Cr | ₹10 Cr |
| -₹154 Cr | -₹73 Cr | -₹157 Cr | -₹28 Cr | -₹112 Cr | -₹48 Cr | -₹31 Cr | ₹11 Cr | -₹11 Cr | -₹14 Cr | ₹13 Cr | -₹5 Cr | ₹1 Cr |
| ₹134 Cr | ₹197 Cr | ₹97 Cr | ₹199 Cr | ₹79 Cr | ₹79 Cr | ₹77 Cr | ₹92 Cr | ₹34 Cr | ₹10 Cr | ₹25 Cr | ₹9 Cr | ₹16 Cr |
| ₹65 Cr | ₹137 Cr | ₹43 Cr | ₹152 Cr | ₹29 Cr | ₹48 Cr | ₹57 Cr | ₹71 Cr | ₹24 Cr | ₹7 Cr | ₹26 Cr | ₹8 Cr | ₹15 Cr |
| -₹219 Cr | -₹184 Cr | -₹103 Cr | -₹181 Cr | -₹299 Cr | -₹37 Cr | -₹190 Cr | -₹36 Cr | -₹20 Cr | -₹6 Cr | -₹5 Cr | -₹2 Cr | -₹4 Cr |
| ₹186 Cr | ₹65 Cr | ₹16 Cr | ₹61 Cr | ₹292 Cr | -₹25 Cr | ₹157 Cr | -₹29 Cr | -₹5 Cr | -₹2 Cr | -₹19 Cr | -₹6 Cr | -₹11 Cr |
| ₹32 Cr | ₹19 Cr | -₹44 Cr | ₹32 Cr | ₹22 Cr | -₹14 Cr | ₹23 Cr | ₹6 Cr | -₹2 Cr | -₹35 L | ₹2 Cr | ₹4 L | ₹37 L |
| ₹44 Cr | ₹25 Cr | ₹69 Cr | ₹37 Cr | ₹15 Cr | ₹29 Cr | ₹6 Cr | ₹63 L | ₹2 Cr | ₹3 Cr | ₹1 Cr | ₹99 L | ₹62 L |
| -₹80 L | ₹38 L | -₹25 L | ₹20 L | ₹0 | ₹10,000 | -₹20,000 | -₹49 L | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| ₹75 Cr | ₹44 Cr | ₹25 Cr | ₹69 Cr | ₹37 Cr | ₹15 Cr | ₹29 Cr | ₹6 Cr | ₹76 L | ₹2 Cr | ₹3 Cr | ₹1 Cr | ₹99 L |
Fundamental Ratios
Consolidated
Standalone
Rossari Biotech Share Price
446.50-8.30 (-1.82%)
-31.77% past 1 Year
Technical meters
Oscillators
Strong SellSellNeutralBuyStrong Buy
Bullish signals: 0
Bearish signals: 6 out of 9 oscillators
RSI
37.78Sell
STOCH %K
39.65Neutral
MACD Level(12,26)
-13.87Sell
Ultimate Oscillator
42.39Sell
Aroon Oscillator
-86.00Sell
BOP
-0.48Sell
CCI
-52.55Neutral
Williams %R
-60.35Neutral
Momentum
-10.50Sell
Moving averages
Strong SellSellNeutralBuyStrong Buy
Bullish signals: 1
Bearish signals: 8 out of 9 moving averages
EMA 9
446.98Sell
SMA 9
442.51Buy
EMA 21
458.48Sell
SMA 21
459.41Sell
EMA 50
479.00Sell
SMA 50
487.64Sell
EMA 200
519.92Sell
SMA 200
508.41Sell
WMA 20
448.64Sell
Pivot
Pivot
Classic
Resistance 5
589.65
Resistance 4
556.40
Resistance 3
523.15
Resistance 2
489.90
Resistance 1
472.35
Pivot
456.65
Support 1
439.10
Support 2
423.40
Support 3
390.15
Support 4
356.90
Support 5
323.65
High & lows
1 Day
1 Week
1 Month
3 Months
6 Months
Year to Date
1 Year
3 Years
5 Years
10 Years
All Time
Rossari Biotech Share Price
446.50-8.30 (-1.82%)
-31.77% past 1 Year
Shareholding summary
Shareholding Pattern
Quarterly
Yearly
Name
Promoters
FII
DII - Others
DII - MFs
Retail & Others
| Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 |
|---|---|---|---|---|---|
| 68.14% | 68.15% | 68.16% | 68.17% | 68.17% | 68.18% |
| 2.03% | 2.18% | 2.32% | 2.70% | 3.48% | 3.98% |
| 4.87% | 4.83% | 4.78% | 4.91% | 4.42% | 4.30% |
| 9.77% | 13.38% | 13.47% | 13.27% | 13.42% | 13.29% |
| 15.19% | 11.46% | 11.27% | 10.95% | 10.51% | 10.25% |
Bulk & block deals
Name
Bhupesh Kumar Lodha
Goldman Sachs Funds Goldman Sachs India Equity Portfolio
Goldman Sachs India Fund Limited
Public Sector Pension Investment Board
Iifl Special Opportunities Fund Series 4
Plutus Wealth Management Llp
Two Roads Trading Private Limited
Two Roads Trading Private Limited
Vaibhav Stock And Derivatives Broking Private Limited
Vaibhav Stock And Derivatives Broking Private Limited
| Deal Date | Action | Deal Value | Deal Price | Qty Traded | Deal Type | %Stake Traded | Exchange |
|---|---|---|---|---|---|---|---|
| 30 Apr 2026 | Purchase | 14.65 Cr | ₹491.50 | 2.98 L | Bulk | 0.537963 | NSE |
| 20 Sep 2021 | Purchase | 98.50 Cr | ₹1,478.65 | 6.66 L | Block | 1.202538 | BSE |
| 20 Sep 2021 | Sell | 98.50 Cr | ₹1,478.65 | 6.66 L | Block | 1.202538 | BSE |
| 19 Jul 2021 | Purchase | 20.85 Cr | ₹1,249.50 | 1.67 L | Block | 0.30125 | NSE |
| 19 Jul 2021 | Sell | 20.85 Cr | ₹1,249.50 | 1.67 L | Block | 0.30125 | NSE |
| 02 Sep 2020 | Purchase | 23.21 Cr | ₹773.82 | 3 L | Bulk | 0.541574 | NSE |
| 27 Jul 2020 | Purchase | 20.12 Cr | ₹717.68 | 2.80 L | Bulk | 0.506191 | NSE |
| 27 Jul 2020 | Sell | 20.13 Cr | ₹718.07 | 2.80 L | Bulk | 0.506191 | NSE |
| 24 Jul 2020 | Purchase | 23.31 Cr | ₹758.13 | 3.07 L | Bulk | 0.555106 | NSE |
| 24 Jul 2020 | Sell | 23.32 Cr | ₹758.44 | 3.07 L | Bulk | 0.555106 | NSE |
Insider trading & SAST
Client name
Sbi Mutual Fund
Yash Sunil Chari
Yash Sunil Chari & Other
Chari Family Trust
Sunil Srinivasan Chari
Jyotishna Sunil Chari
Yash Sunil Chari & Others
Sunil Srinivasan Chari
Jyotishna Sunil Chari
Chari Family Trust - In The Name Of Sunil Srinivasan Chari & Jyotishna Sunil Chari
| Reported on | Client category | Action | %Stake traded | Holding % post deal | Deal value | Deal price | Qty traded | Deal period | Deal mode | Post transaction holding | Insider/SAST | Regulation type | Security type |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 26 May 2026 | — | Disposal | 0.28 | 2.97 | 0 | — | 1.57 L | 17 Apr 2026 | Market | 16,48,093 | SAST | 29(2) | — |
| 13 Oct 2025 | Promoter | Acquisition | 4.15 | 4.45 | 0 | — | 23 L | 28 Aug 2025 | Off Market / Inter se transfer | 24,65,000 | SAST | 29(2) | — |
| 13 Oct 2025 | Other | Acquisition | 15.62 | — | 0 | — | 88 L | 28 Aug 2025 | - | — | SAST | 10(6) | — |
| 13 Oct 2025 | Promoter | Acquisition | 9.03 | 9.23 | 0 | — | 50 L | 28 Aug 2025 | Off Market / Inter se transfer | 51,10,000 | SAST | 29(2) | — |
| 13 Oct 2025 | Promoter | Disposal | 15.89 | 13.17 | 0 | — | 88 L | 28 Aug 2025 | Off Market / Inter se transfer | 72,89,320 | SAST | 29(2) | — |
| 13 Oct 2025 | Promoter | Acquisition | 2.71 | 4.52 | 0 | — | 15 L | 28 Aug 2025 | Off Market / Inter se transfer | 25,00,330 | SAST | 29(2) | — |
| 18 Sep 2025 | Other | Acquisition | 15.89 | — | 0 | — | 88 L | 28 Aug 2025 | — | — | SAST | 10(5) | — |
| 29 Aug 2025 | Promoter | Disposal | 15.893944 | 13.17 | 543.18 Cr | ₹617.25 | 88 L | 28 Aug 2025 | Gift | 72,89,320 | Insider Trading | — | Equity Shares |
| 29 Aug 2025 | Promoter Group | Acquisition | 2.709195 | 4.52 | 92.59 Cr | ₹617.25 | 15 L | 28 Aug 2025 | Gift | 25,00,330 | Insider Trading | — | Equity Shares |
| 29 Aug 2025 | Promoter Group | Acquisition | 9.03065 | 9.23 | 308.62 Cr | ₹617.25 | 50 L | 28 Aug 2025 | Gift | 51,10,000 | Insider Trading | — | Equity Shares |
Rossari Biotech Share Price
446.50-8.30 (-1.82%)
-31.77% past 1 Year
Rossari Biotech Limited is one of the leading specialty chemicals manufacturing companies in India providing customized solutions to specific industrial and production requirements of its customers primarily in the FMCG,
Corporate Actions
Date
Type
Details
Company details
Rossari Biotech Share Price
446.50-8.30 (-1.82%)
-31.77% past 1 Year
Corporate filings & documents
Announcements
Annual reports
Concalls & investor presentations
Rossari Biotech Share Price
446.50-8.30 (-1.82%)
-31.77% past 1 Year
News
Rossari Biotech prioritises KSA project, limits India capex in FY27–FY28
Equity
ROSSARI
Rossari Biotech projects Rs 30-50 crores FY27 pharma revenue ramp-up
Equity
ROSSARI
Rossari Biotech targets margin improvement via portfolio optimisation and capacity utilisation
Equity
ROSSARI
Rossari Biotech sets Q1 FY27 EBITDA margin baseline, targets 15 percent plus in 2 years
Equity
ROSSARI
Rossari Biotech upbeat on FY28 growth outlook on improved EO availability
Equity
ROSSARI
Rossari Biotech maintains FY27 topline growth guidance despite strong Q1 performance
Equity
ROSSARI
Rossari Biotech flags El Nino-led challenges for agriculture segment outlook
Equity
ROSSARI
Rossari Biotech faces uncertain revenue and profit growth outlook amid global headwinds
Equity
ROSSARI
Rossari Biotech Q1 EBITDA rises year-on-year but margin moderates slightly
Equity
ROSSARI
Rossari Biotech Q1 revenue rises year-on-year, strong topline momentum continues
Equity
ROSSARI
Rossari Biotech Q1 FY26 consolidated net profit edges higher YoY
Equity
ROSSARI
Rossari Biotech to host Q1 earnings conference call on July 20 at 5 PM
Equity
ROSSARI
Rossari Biotech - Quaterly Results
Equity
ROSSARI
Rossari Biotech Q4 EBITDA Rises 11% YoY to Rs 77.20 Crores, Margin at 11.28%
Equity
ROSSARI
Rossari Biotech Q4FY26 Net Profit Rises 33.6% YoY to Rs 46 Cr, Revenue Up 20.7% to Rs 700 Cr.
Equity
ROSSARI
Rossari Biotech reports Profit after tax of 54.73 Crores, in the March 2026 quarter
Equity
ROSSARI
Rossari Biotech informs about disclosure
Equity
ROSSARI
Rossari Biotech informs about updates
Equity
ROSSARI
Rossari Biotech Outlines Priorities for Capacity Utilization, Product Portfolio, Financial Discipline in Concall.
Equity
ROSSARI
Rossari Biotech Board Approves Greenfield Specialty Chemicals Facility in Saudi Arabia.
Equity
ROSSARI

